acetylcarnitine and hydroxyurea

acetylcarnitine has been researched along with hydroxyurea in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A	1
Bosboom, WM; Iannaccone, ST; van den Berg, LH; Vrancken, AF; Wadman, RI; Wokke, JH	1
Bosboom, WM; Iannaccone, ST; van den Berg, LH; van der Pol, WL; Vrancken, AF; Wadman, RI; Wokke, JH	1

Reviews

2 review(s) available for acetylcarnitine and hydroxyurea

Article	Year
Drug treatment for spinal muscular atrophy types II and III. The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12 Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Phenylbutyrates; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone; Valproic Acid	2011
Drug treatment for spinal muscular atrophy types II and III. The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4 Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Phenylbutyrates; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone; Valproic Acid	2012

Article

Year

Drug treatment for spinal muscular atrophy types II and III.

The Cochrane database of systematic reviews, 2011, Dec-07, Issue:12

Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Phenylbutyrates; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone; Valproic Acid

2011

Drug treatment for spinal muscular atrophy types II and III.

The Cochrane database of systematic reviews, 2012, Apr-18, Issue:4

Topics: Acetylcarnitine; Adolescent; Amines; Child; Child, Preschool; Creatine; Cyclohexanecarboxylic Acids; Disease Progression; Gabapentin; gamma-Aminobutyric Acid; Humans; Hydroxyurea; Neuroprotective Agents; Phenylbutyrates; Randomized Controlled Trials as Topic; Spinal Muscular Atrophies of Childhood; Thyrotropin-Releasing Hormone; Valproic Acid

2012

Other Studies

1 other study(ies) available for acetylcarnitine and hydroxyurea

Article	Year
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species. Chemical research in toxicology, 2010, Volume: 23, Issue:1 Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship	2010